Gabapentin Tablets, USP
Recall D-0155-2018, part of FDA recall event 78697. See Solco Healthcare US's company page.
Solco Healtcare US LLC started this Class II drug recall on Dec 4, 2017 (voluntary: firm initiated); FDA lists it as terminated, terminated Feb 25, 2019.
- Classification: Class II
- Started: Dec 4, 2017
- Status: Terminated
Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg
- Product
- Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50
- Quantity
- N/A
- Lots and codes
- Lot # 7700656A
- Distribution
- Product was distributed in Mason, OH.
- Recalling firm
- Solco Healtcare US LLC, Cranbury, NJ, United States
- How the firm notified
- Letter
- FDA classified
- Jan 5, 2018
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports